Int'l : +1(646) 600-5072 | query@kbvresearch.com
Published Date : 29-12-2017 | Pages: 82 | Formats: PDF |
The North America Stroke Management Market would witness market growth of 6.8% CAGR during the forecast period (2018 – 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth. Rising investments to upgrade healthcare systems and demand for technologically advanced devices for rapid & accurate distribution of medicines are the factors that are driving the market in the region. Research and development activities in the region would further add to the market attractiveness in the region.
Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.
Scope of the Study
Market Segmentation:
By Type
By Application
By Country
Companies Profiled
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Stroke Management Market, by Type
1.4.2 North America Stroke Management Market, by Application
1.4.3 North America Stroke Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Stroke Management Market by Type
3.1.1 North America Diagnostics Stroke Management Market by Country
3.1.1.1 North America Stroke Management Market by Diagnostics Type
3.1.1.1.1 North America Stroke Management Computed Tomography Scan (CT Scan) Market by Country
3.1.1.1.2 North America Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
3.1.1.1.3 North America Stroke Management Echocardiography Market by Country
3.1.1.1.4 North America Stroke Management Carotid Ultrasound Market by Country
3.1.1.1.5 North America Stroke Management Cerebral Angiography Market by Country
3.1.1.1.6 North America Stroke Management Electrocardiography Market by Country
3.1.1.1.7 North America Other Diagnostics Type Stroke Management Market by Country
3.1.2 North America Therapeutics Stroke Management Market by Country
3.1.2.1 North America Stroke Management Market by Therapeutics Type
3.1.2.1.1 North America Tissue Plasminogen Activator Stroke Management Market by Country
3.1.2.1.2 North America Anticoagulant Stroke Management Market by Country
3.1.2.1.3 North America Antiplatelet Stroke Management Market by Country
3.1.2.1.4 North America Other Therapeutics Type Stroke Management Market by Country
Chapter 4. North America Stroke Management Market by Application
4.1.1 North America Ischemic Stroke Management Market by Country
4.1.2 North America Haemorrhagic Stroke Management Market by Country
Chapter 5. North America Stroke Management Market by Country
5.1 US Stroke Management Market
5.1.1 US Stroke Management Market by Type
5.1.1.1 US Stroke Management Market by Diagnostics Type
5.1.1.2 US Stroke Management Market by Therapeutics Type
5.1.2 US Stroke Management Market by Application
5.2 Canada Stroke Management Market
5.2.1 Canada Stroke Management Market by Type
5.2.1.1 Canada Stroke Management Market by Diagnostics Type
5.2.1.2 Canada Stroke Management Market by Therapeutics Type
5.2.2 Canada Stroke Management Market by Application
5.3 Mexico Stroke Management Market
5.3.1 Mexico Stroke Management Market by Type
5.3.1.1 Mexico Stroke Management Market by Diagnostics Type
5.3.1.2 Mexico Stroke Management Market by Therapeutics Type
5.3.2 Mexico Stroke Management Market by Application
5.4 Rest of North America Stroke Management Market
5.4.1 Rest of North America Stroke Management Market by Type
5.4.1.1 Rest of North America Stroke Management Market by Diagnostics Type
5.4.1.2 Rest of North America Stroke Management Market by Therapeutics Type
5.4.2 Rest of North America Stroke Management Market by Application
Chapter 6. Company Profiles
6.1 B. Braun Melsungen AG.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 ABBOTT
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional & Segmental Analysis
6.2.4 Research & Development Expense
6.3 Cardinal Health
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental Analysis
6.4 Medtronic Plc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 General Electric (GE) (GE Healthcare)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Siemens Healthineers
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental Analysis
6.6.4 Research & Development Expense
6.7 Bristol-Myers Squibb
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Merck & Company Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expense
6.9 Glaxosmithkline Plc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental Analysis
6.9.4 Research & Development Expense
TABLE 1 NORTH AMERICA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 2 NORTH AMERICA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 3 NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 4 NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 5 NORTH AMERICA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6 NORTH AMERICA DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7 NORTH AMERICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 8 NORTH AMERICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 9 NORTH AMERICA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10 NORTH AMERICA STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11 NORTH AMERICA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 12 NORTH AMERICA STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 13 NORTH AMERICA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14 NORTH AMERICA STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15 NORTH AMERICA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16 NORTH AMERICA STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17 NORTH AMERICA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18 NORTH AMERICA STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19 NORTH AMERICA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20 NORTH AMERICA STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21 NORTH AMERICA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 22 NORTH AMERICA OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 23 NORTH AMERICA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24 NORTH AMERICA THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25 NORTH AMERICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 26 NORTH AMERICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 27 NORTH AMERICA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 28 NORTH AMERICA TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 29 NORTH AMERICA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30 NORTH AMERICA ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31 NORTH AMERICA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32 NORTH AMERICA ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33 NORTH AMERICA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34 NORTH AMERICA OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35 NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 36 NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 37 NORTH AMERICA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 38 NORTH AMERICA ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 39 NORTH AMERICA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 40 NORTH AMERICA HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 41 NORTH AMERICA STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 42 NORTH AMERICA STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 43 US STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 44 US STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 45 US STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 46 US STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 47 US STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 48 US STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 49 US STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 50 US STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 51 US STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 52 US STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 53 CANADA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 54 CANADA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 55 CANADA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 56 CANADA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 57 CANADA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 58 CANADA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 59 CANADA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 60 CANADA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 61 CANADA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 62 CANADA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 63 MEXICO STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 64 MEXICO STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 65 MEXICO STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 66 MEXICO STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 67 MEXICO STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 68 MEXICO STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 69 MEXICO STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 70 MEXICO STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 71 MEXICO STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 72 MEXICO STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 73 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 74 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 75 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 76 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 77 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 78 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 79 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 80 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 81 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 82 REST OF NORTH AMERICA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 83 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 84 KEY INFORMATION – ABBOTT
TABLE 85 KEY INFORMATION – CARDINAL HEALTH
TABLE 86 BUSINESS SEGMENT – CARDINAL HEALTH
TABLE 87 KEY INFORMATION – MEDTRONIC PLC
TABLE 88 KEY INFORMATION – MEDTRONIC
TABLE 89 KEY INFORMATION – GENERAL ELECTRIC (GE)
TABLE 90 KEY INFORMATION - SIEMENS HEALTHINEERS
TABLE 91 KEY INFORMATION - BRISTOL-MYERS SQUIBB
TABLE 92 KEY INFORMATION - MERCK & COMPANY INC.
TABLE 93 KEY INFORMATION - GLAXOSMITHKLINE PLC.